Clinical Trials Browser

Phase 1/2 × pyrotinib × Thoracic × Clear all

NCT05745740 2023-11-27

A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung